Blade Therapeutics, Inc.  
South San Francisco, USA
|
|
Description:
Blade Therapeutics is a private biopharmaceutical company advancing novel, selective small-molecule therapies to treat debilitating diseases of lung and liver fibrosis. The company has developed a diversified small molecule portfolio, including two clinical stage assets (BLD-2660 and BLD-0409) and several preclinical stage assets, through a combination of in-house drug discovery and selective in-licensing.
Blade Therapeutics is a private biopharmaceutical company advancing novel, selective small-molecule therapies to treat debilitating diseases of lung and liver fibrosis. The company has developed a diversified small molecule portfolio, including two clinical stage assets (BLD-2660 and BLD-0409) and several preclinical stage assets, through a combination of in-house drug discovery and selective in-licensing.